Abstract

Prevention guidelines and EAS/ESC guidelines for the treatment of dyslipidaemias: A look to the future

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Low-Density Lipoprotein Cholesterol Reduction and Prevention of Cardiovascular Disease
Evan A Stein
Mayo Clinic Proceedings | VOL. 84
Evan A SteinEvan A Stein
01 Apr 2009
Dyslipidemia.
G.B John Mancini ... Lawrence A Leiter
Canadian Journal of Diabetes | VOL. Suppl 42 1
G.B John Mancini, et. al.G.B John Mancini ... Lawrence A Leiter
01 Apr 2018
Intensive Lipid Intervention in the Post-ENHANCE Era
James H O'Keefe ... Carl J Lavie
Mayo Clinic Proceedings | VOL. 83
James H O'Keefe, et. al.James H O'Keefe ... Carl J Lavie
01 Aug 2008
Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics.
Makan Khoshnejad ... Daniel J Rader
Molecular Therapy | VOL. 27
Makan Khoshnejad, et. al.Makan Khoshnejad ... Daniel J Rader
15 Nov 2018
View more papers

More From: Atherosclerosis

Paper Title
Journal
Date
Author
Editorial Board
-
Atherosclerosis | VOL. 394
--
01 Jul 2024
Interplay between epigenetic mechanisms and transcription factors in atherosclerosis
Misbah Aziz ... Abdul Waheed Khan
Atherosclerosis | VOL. 395
Misbah Aziz, et. al.Misbah Aziz ... Abdul Waheed Khan
06 Jun 2024
Operationalizing the implications of subclinical vascular risk composites using the concept of vascular frailty
Szu-Ying Lee ... Chia-Ter Chao
Atherosclerosis | VOL. -
Szu-Ying Lee, et. al.Szu-Ying Lee ... Chia-Ter Chao
06 Jun 2024
AMPK-mediated regulation of endogenous cholesterol synthesis does not affect atherosclerosis in a murine Pcsk9-AAV model
Tyler K.T Smith ... Morgan D Fullerton
Atherosclerosis | VOL. -
Tyler K.T Smith, et. al.Tyler K.T Smith ... Morgan D Fullerton
01 Jun 2024
View more papers